Needham & Company Reiterates a 'Buy' on Cubist Pharmaceuticals (CBST); 2Q11 Cubicin Sales Slightly Above Expectations and Guidance Raised for the Year
Go back to Needham & Company Reiterates a 'Buy' on Cubist Pharmaceuticals (CBST); 2Q11 Cubicin Sales Slightly Above Expectations and Guidance Raised for the Year| Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) | Delayed: 101.94 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $101.94 | 52 Week High | $101.99 | |||
| Open | $3.23 | 52 Week Low | $58.50 | |||
| Day High | $101.94 | P/E | N/A | |||
| Day Low | $101.94 | EPS | $-0.27 | |||
| Volume | 3,714 | |||||
